Amylin Pharmaceuticals Stock Price, News & Analysis (NASDAQ:AMLN)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Amylin Pharmaceuticals (NASDAQ:AMLN)

Amylin Pharmaceuticals logoAmylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. It markets two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. It is also markets a diabetes treatment, BYDUREON (exenatide extended-release for injectable suspension). BYDUREON is an extended-release medication for type 2 diabetes that provides continuous glycemic control in a once-weekly dose. Amylin maintains a research and early development program focused on peptide and protein therapeutics. It has also entered into alliances and business initiatives, including its relationship with Biocon, Limited (Biocon) to develop pharmaceutical products, including AC165198, a peptide hybrid drug candidate for diabetes, which was developed from its phybrid technology platform. In August 2012, Bristol-Myers Squibb Company acquired the Company.

Receive AMLN News and Ratings via Email

Sign-up to receive the latest news and ratings for AMLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:AMLN
CUSIPN/A
Phone+1-858-5522200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Amylin Pharmaceuticals (NASDAQ:AMLN) Frequently Asked Questions

What is Amylin Pharmaceuticals' stock symbol?

Amylin Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMLN."

Who are some of Amylin Pharmaceuticals' key competitors?

How do I buy Amylin Pharmaceuticals stock?

Shares of Amylin Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Amylin Pharmaceuticals?

Amylin Pharmaceuticals' mailing address is 9360 Towne Centre Dr, SAN DIEGO, CA 92121-3057, United States. The biopharmaceutical company can be reached via phone at +1-858-5522200.


MarketBeat Community Rating for Amylin Pharmaceuticals (AMLN)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Amylin Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amylin Pharmaceuticals (NASDAQ:AMLN) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Amylin Pharmaceuticals (NASDAQ:AMLN) Earnings History and Estimates Chart

Earnings by Quarter for Amylin Pharmaceuticals (NASDAQ:AMLN)

Amylin Pharmaceuticals (NASDAQ AMLN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2012($0.27)($0.23)ViewN/AView Earnings Details
2/6/2012($0.16)$0.09ViewN/AView Earnings Details
10/19/2011($0.13)($0.07)ViewN/AView Earnings Details
7/26/2011($0.17)($0.21)ViewN/AView Earnings Details
4/18/2011($0.23)($0.26)ViewN/AView Earnings Details
1/26/2011($0.32)($0.13)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.34)($0.31)ViewN/AView Earnings Details
7/21/2010Q2 2010($0.29)($0.28)ViewN/AView Earnings Details
4/19/2010Q1 2010($0.28)($0.27)ViewN/AView Earnings Details
1/27/2010Q4 2009($0.27)($0.32)ViewN/AView Earnings Details
10/20/2009Q3 2009($0.30)($0.19)ViewN/AView Earnings Details
7/21/2009Q2 2009($0.35)($0.36)ViewN/AView Earnings Details
4/16/2009Q1 2009($0.35)($0.34)ViewN/AView Earnings Details
1/27/2009Q4 2008($0.51)($0.36)ViewN/AView Earnings Details
10/21/2008Q3 2008($0.51)($0.46)ViewN/AView Earnings Details
7/21/2008Q2 2008($0.50)($0.47)ViewN/AView Earnings Details
4/21/2008Q1 2008($0.48)($0.51)ViewN/AView Earnings Details
1/28/2008Q4 2007($0.44)($0.57)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Amylin Pharmaceuticals (NASDAQ:AMLN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Amylin Pharmaceuticals (NASDAQ:AMLN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Amylin Pharmaceuticals (NASDAQ AMLN)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Amylin Pharmaceuticals (NASDAQ AMLN) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Amylin Pharmaceuticals (NASDAQ:AMLN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amylin Pharmaceuticals (NASDAQ:AMLN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amylin Pharmaceuticals (NASDAQ AMLN) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.